Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 3
1990 2
1991 3
1992 1
1993 1
1996 3
1997 2
1998 2
1999 3
2000 6
2001 4
2002 3
2003 7
2004 3
2005 6
2006 11
2007 7
2008 14
2009 13
2010 19
2011 32
2012 36
2013 42
2014 56
2015 66
2016 83
2017 93
2018 81
2019 109
2020 129
2021 142
2022 154
2023 163
2024 26

Text availability

Article attribute

Article type

Publication date

Search Results

1,159 results

Results by year

Filters applied: . Clear all
Page 1
Molecular subtyping and genomic profiling expand precision medicine in refractory metastatic triple-negative breast cancer: the FUTURE trial.
Jiang YZ, Liu Y, Xiao Y, Hu X, Jiang L, Zuo WJ, Ma D, Ding J, Zhu X, Zou J, Verschraegen C, Stover DG, Kaklamani V, Wang ZH, Shao ZM. Jiang YZ, et al. Among authors: zuo wj. Cell Res. 2021 Feb;31(2):178-186. doi: 10.1038/s41422-020-0375-9. Epub 2020 Jul 27. Cell Res. 2021. PMID: 32719455 Free PMC article. Clinical Trial.
High-resolution silkworm pan-genome provides genetic insights into artificial selection and ecological adaptation.
Tong X, Han MJ, Lu K, Tai S, Liang S, Liu Y, Hu H, Shen J, Long A, Zhan C, Ding X, Liu S, Gao Q, Zhang B, Zhou L, Tan D, Yuan Y, Guo N, Li YH, Wu Z, Liu L, Li C, Lu Y, Gai T, Zhang Y, Yang R, Qian H, Liu Y, Luo J, Zheng L, Lou J, Peng Y, Zuo W, Song J, He S, Wu S, Zou Y, Zhou L, Cheng L, Tang Y, Cheng G, Yuan L, He W, Xu J, Fu T, Xiao Y, Lei T, Xu A, Yin Y, Wang J, Monteiro A, Westhof E, Lu C, Tian Z, Wang W, Xiang Z, Dai F. Tong X, et al. Among authors: zuo w. Nat Commun. 2022 Sep 24;13(1):5619. doi: 10.1038/s41467-022-33366-x. Nat Commun. 2022. PMID: 36153338 Free PMC article.
Targeting p21Cip1 highly expressing cells in adipose tissue alleviates insulin resistance in obesity.
Wang L, Wang B, Gasek NS, Zhou Y, Cohn RL, Martin DE, Zuo W, Flynn WF, Guo C, Jellison ER, Kim T, Prata LGPL, Palmer AK, Li M, Inman CL, Barber LS, Al-Naggar IMA, Zhou Y, Du W, Kshitiz, Kuchel GA, Meves A, Tchkonia T, Kirkland JL, Robson P, Xu M. Wang L, et al. Among authors: zuo w. Cell Metab. 2022 Jan 4;34(1):75-89.e8. doi: 10.1016/j.cmet.2021.11.002. Epub 2021 Nov 22. Cell Metab. 2022. PMID: 34813734 Free PMC article.
NAD+ and cardiovascular diseases.
Lin Q, Zuo W, Liu Y, Wu K, Liu Q. Lin Q, et al. Among authors: zuo w. Clin Chim Acta. 2021 Apr;515:104-110. doi: 10.1016/j.cca.2021.01.012. Epub 2021 Jan 21. Clin Chim Acta. 2021. PMID: 33485900 Review.
Subtyping-based platform guides precision medicine for heavily pretreated metastatic triple-negative breast cancer: The FUTURE phase II umbrella clinical trial.
Liu Y, Zhu XZ, Xiao Y, Wu SY, Zuo WJ, Yu Q, Cao AY, Li JJ, Yu KD, Liu GY, Wu J, Sun T, Cui JW, Lv Z, Li HP, Zhu XY, Jiang YZ, Wang ZH, Shao ZM. Liu Y, et al. Among authors: zuo wj. Cell Res. 2023 May;33(5):389-402. doi: 10.1038/s41422-023-00795-2. Epub 2023 Mar 27. Cell Res. 2023. PMID: 36973538 Free PMC article. Clinical Trial.
Review of guidelines regarding mesh implants.
Yang B, Zuo W, Wu J. Yang B, et al. Among authors: zuo w. Eur J Surg Oncol. 2021 Nov;47(11):2709-2710. doi: 10.1016/j.ejso.2021.07.004. Epub 2021 Jul 7. Eur J Surg Oncol. 2021. PMID: 34462142 No abstract available.
1,159 results